Literature DB >> 18813350

Distinct patterns of structural and numerical chromosomal instability characterize sporadic ovarian cancer.

Jane Bayani1, Jana Paderova, Joan Murphy, Barry Rosen, Maria Zielenska, Jeremy A Squire.   

Abstract

Sporadic ovarian cancer is a particularly aggressive tumor characterized by highly abnormal karyotypes exhibiting many features of genomic instability. More complex genomic changes in tumors arise as a consequence of chromosomal instability (CIN), which can generate both numerical [(N)-CIN] and structural chromosomal instability [(S)-CIN]. In this study, molecular cytogenetic analysis was used to evaluate the relative levels of both (N)-CIN and (S)-CIN. Six tumors had a near-diploid chromosome number, two were near-tetraploid, and two were near-triploid. (N)-CIN levels increased as a function of overall tumor genomic content, with near-diploid tumors exhibiting numerical instability indices ranging from 7.0 to 21.0 and near-tetraploid and triploid tumors exhibiting instability indices ranging from 24.9 to 54.9. In contrast, the extent of (S)-CIN was generally more evident in the diploid tumors compared with the near-tetraploid tumors. To determine whether the associated chromosomal constitution and/or ploidy changes were influenced by mitotic segregation errors, centrosome analyses were performed on all 10 tumors. The near-diploid tumors, with the lowest numerical change, were observed to possess fewer cells with centrosome abnormalities (5.5% to 14.0%), whereas the near-tetraploid tumors possessed much higher levels of (N)-CIN and were characterized by a trend of elevating percentages of cells with abnormal centrosomes (16.0% to 20.5%). These observations suggest that two distinct processes governing genome stability may be disrupted in ovarian cancer: those that impact on numerical segregation and ploidy of chromosomes and those that affect the fidelity of DNA repair and lead to structural aberrations.

Entities:  

Mesh:

Year:  2008        PMID: 18813350      PMCID: PMC2546587          DOI: 10.1593/neo.08584

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  54 in total

Review 1.  Genome maintenance mechanisms for preventing cancer.

Authors:  J H Hoeijmakers
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

Review 2.  Roles of BRCA1 in DNA damage repair: a link between development and cancer.

Authors:  Chu-Xia Deng; Rui-Hong Wang
Journal:  Hum Mol Genet       Date:  2003-04-01       Impact factor: 6.150

Review 3.  Centrosome aberrations: cause or consequence of cancer progression?

Authors:  Erich A Nigg
Journal:  Nat Rev Cancer       Date:  2002-11       Impact factor: 60.716

4.  Mammalian mad2 and bub1/bubR1 recognize distinct spindle-attachment and kinetochore-tension checkpoints.

Authors:  D A Skoufias; P R Andreassen; F B Lacroix; L Wilson; R L Margolis
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

5.  Tetraploid state induces p53-dependent arrest of nontransformed mammalian cells in G1.

Authors:  P R Andreassen; O D Lohez; F B Lacroix; R L Margolis
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

6.  Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas.

Authors:  Jane Bayani; Maria Zielenska; Ajay Pandita; Khaldoun Al-Romaih; Jana Karaskova; Karen Harrison; Julia A Bridge; Poul Sorensen; Paul Thorner; Jeremy A Squire
Journal:  Genes Chromosomes Cancer       Date:  2003-01       Impact factor: 5.006

7.  Genetic analysis of early- versus late-stage ovarian tumors.

Authors:  V Shridhar; J Lee; A Pandita; S Iturria; R Avula; J Staub; M Morrissey; E Calhoun; A Sen; K Kalli; G Keeney; P Roche; W Cliby; K Lu; R Schmandt; G B Mills; R C Bast; C D James; F J Couch; L C Hartmann; J Lillie; D I Smith
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

8.  Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells.

Authors:  Rainer Kimmig; Pauline Wimberger; Peter Hillemanns; Thomas Kapsner; Claudia Caspari; Hermann Hepp
Journal:  Gynecol Oncol       Date:  2002-01       Impact factor: 5.482

9.  Comparative genomic hybridization analysis identifies gains of 1p35 approximately p36 and chromosome 19 in osteosarcoma.

Authors:  M Zielenska; J Bayani; A Pandita; S Toledo; P Marrano; J Andrade; A Petrilli; P Thorner; P Sorensen; J A Squire
Journal:  Cancer Genet Cytogenet       Date:  2001-10-01

10.  Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays.

Authors:  Jane Bayani; James D Brenton; Pascale F Macgregor; Ben Beheshti; Monique Albert; Dhani Nallainathan; Jana Karaskova; Barry Rosen; Joan Murphy; Stephanie Laframboise; Brent Zanke; Jeremy A Squire
Journal:  Cancer Res       Date:  2002-06-15       Impact factor: 12.701

View more
  21 in total

1.  Dinosaurs and ancient civilizations: reflections on the treatment of cancer.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2010-12       Impact factor: 5.715

2.  Genomic instability and copy-number heterogeneity of chromosome 19q, including the kallikrein locus, in ovarian carcinomas.

Authors:  Jane Bayani; Paula Marrano; Cassandra Graham; Yingye Zheng; Lin Li; Dionyssios Katsaros; Heini Lassus; Ralf Butzow; Jeremy A Squire; Eleftherios P Diamandis
Journal:  Mol Oncol       Date:  2010-08-11       Impact factor: 6.603

3.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

4.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

5.  Tetraploid cells from cytokinesis failure induce aneuploidy and spontaneous transformation of mouse ovarian surface epithelial cells.

Authors:  Lei Lv; Tianwei Zhang; Qiyi Yi; Yun Huang; Zheng Wang; Heli Hou; Huan Zhang; Wei Zheng; Qiaomei Hao; Zongyou Guo; Howard J Cooke; Qinghua Shi
Journal:  Cell Cycle       Date:  2012-08-01       Impact factor: 4.534

Review 6.  A clinical overview of centrosome amplification in human cancers.

Authors:  Jason Yongsheng Chan
Journal:  Int J Biol Sci       Date:  2011-10-16       Impact factor: 6.580

7.  Effects of long-term norepinephrine treatment on normal immortalized ovarian and fallopian tube cells.

Authors:  Sweta Dash; Sean Yoder; Tania Mesa; Andrew Smith; Ling Cen; Steven Eschrich; Guillermo N Armaiz-Pena; Alvaro N A Monteiro
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

8.  NuMA overexpression in epithelial ovarian cancer.

Authors:  Anke Brüning-Richardson; Jaqueline Bond; Rawiah Alsiary; Julie Richardson; David A Cairns; Luci McCormac; Richard Hutson; Philip A Burns; Nafisa Wilkinson; Geoff D Hall; Ewan E Morrison; Sandra M Bell
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

9.  Induction of polyploidy by nuclear fusion mechanism upon decreased expression of the nuclear envelope protein LAP2β in the human osteosarcoma cell line U2OS.

Authors:  Shirley Oren Ben-Shoshan; Amos J Simon; Jasmine Jacob-Hirsch; Sigal Shaklai; Nurit Paz-Yaacov; Ninette Amariglio; Gideon Rechavi; Luba Trakhtenbrot
Journal:  Mol Cytogenet       Date:  2014-01-28       Impact factor: 2.009

Review 10.  Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies.

Authors:  Karuna Mittal; Jaspreet Kaur; Meghan Jaczko; Guanhao Wei; Michael S Toss; Emad A Rakha; Emiel Adrianus Maria Janssen; Håvard Søiland; Omer Kucuk; Michelle Dian Reid; Meenakshi V Gupta; Ritu Aneja
Journal:  Cancer Metastasis Rev       Date:  2020-10-26       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.